Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C
- 24 May 2003
- journal article
- review article
- Published by Elsevier in Antiviral Research
- Vol. 59 (1) , 1-11
- https://doi.org/10.1016/s0166-3542(03)00088-3
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002—June 10-12, 2002Hepatology, 2002
- Retreatment of patients with chronic hepatitis CHepatology, 2002
- Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In VitroJournal of Virology, 2002
- DITTO-HCV early viral kinetics report - novel decline patterns in gen 1 but not gen 2–3 patients treated with PEG-interferon-alfa-2a and ribavirinJournal of Hepatology, 2002
- Hepatitis C virus NS3 serine protease variability and evolution are strongly constrained by the need for structural and functional conservationJournal of Hepatology, 2002
- Peginterferon alfa-2A (40 KD) (PEGASYS) in combination with ribavirin (RBV): efficacy and safety results from a phase III, randomized, double-blind, multicentre study examining effect of duration of treatment and RBV doseJournal of Hepatology, 2002
- Treatment of Acute Hepatitis C with Interferon Alfa-2bNew England Journal of Medicine, 2001
- Ethnicity and cytokine production gauge response of patients with hepatitis C to interferon‐α therapyJournal of Medical Virology, 2001
- Conservation of the Conformation and Positive Charges of Hepatitis C Virus E2 Envelope Glycoprotein Hypervariable Region 1 Points to a Role in Cell AttachmentJournal of Virology, 2001
- Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha InterferonNew England Journal of Medicine, 1986